Completed PHASE4 INTERVENTIONAL 3-arm NCT00778011

Uncomplicated Nausea and Vomiting in the Emergency Department

Ondansetron 4 mg vs. 2 mg vs. Metoclopramide 10 mg for Nausea and Vomiting in the Emergency Department: A Randomized, Double-Blind Clinical Trial

Sponsor: WellSpan Health

Conditions Nausea Vomiting

Interventions Metoclopramide Ondansetron

Updated 6 times since 2017 Last updated: Jun 27, 2012 Started: Nov 30, 2005 Primary completion: Dec 31, 2006 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Nausea and Vomiting and is currently completed. WellSpan Health leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

WellSpan Health

Data source: WellSpan Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• York, United States